Chief Executive Amit Kumar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Sabela Ojea Shares of Anixa Biosciences climbed 14% to $4.47 in after-hours trading after the company presented positive results regarding its Phase 1.

Anixa biosciencesAmit kumarSabela ojeaChief executive amit kumarArticle normalMedical equipment suppliesHealthcare life sciencesMedical diagnostic equipment suppliesSpecialized drugs medicationsMedical devices apparatusDiagnostic therapeutic devicesFinancial performanceNew products servicesResearch developmentCorporate industrial newsProducts services